Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mafco Worldwide LLC, operating as Mafco Health and Nutrition, is the global leader in the production of licorice extract and its derivatives for the pharmaceutical, nutraceutical, and food industries. The company is best known for its Magnasweet® product line, which utilizes glycyrrhizin to provide high-intensity sweetness and effective flavor masking for bitter pharmaceutical actives. Beyond flavoring, Mafco produces active pharmaceutical ingredients (APIs) such as Enoxolone (glycyrrhetinic acid), which is used for its anti-inflammatory and soothing properties in various medical applications. Their products are integral to formulations for cough and cold remedies, gastrointestinal treatments, and personal care products. Headquartered in Camden, New Jersey, Mafco maintains a sophisticated global supply chain and manufacturing infrastructure to ensure high-quality natural ingredients. With over 150 years of experience, the company provides technical expertise in formulation and regulatory support to its global client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MAFCO Health and Nutrition.